Efficacy and Adverse Event Profile in Patients Receiving “Shorter Oral Bedaquiline-containing Multidrug-resistant/Rifampicin-resistant Tuberculosis Regimen” in a Tertiary Care Hospital in Eastern India
Introduction: Multidrug resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) is a leading cause of death in India. To combat this, National TB Elimination Programme, erstwhile RNTCP) has launched “shorter oral bedaquiline (Bdq)-containing MDR/RR-TB regimen” from March 2021 replacing the injectabl...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Col·lecció: | Journal of Advanced Lung Health |
| Matèries: | |
| Accés en línia: | https://journals.lww.com/10.4103/jalh.jalh_64_24 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|